31 juillet 2019
We are delighted to introduce our webinar series on life sciences disputes. The first webinar in the series, Managing cybersecurity risk: a life sciences perspective, was held on 27 June 2019.
In this series opener, our experts addressed:
You can view the webinar here.
Upcoming topics in the series will include:
The second webinar in the series will cover the arbitration process and arbitration clauses, examine the pros and cons of arbitration for the life sciences sector, and discuss the types of disputes that may be more suitable for arbitration.
Find out more and register for this webinar
Potential regulatory consequences, product liability issues (including mitigation) and steps a company can take to protect its reputation are the focus of the third webinar in our series.
The penultimate webinar in our series will examine the available options related to legal challenges that arise when there is a disagreement over a regulator or other decision makers' actions, including litigation in the courts.
In the final webinar in the series, we will address the steps you need to take to preserve valuable innovation as a trade secret, how the law treats an employee/researcher who has worked with confidential information once they move job or start up on their own, the measures that minimise the risk of unauthorised use or disclosure of confidential information, what to do if it happens and what will be involved. We will also discuss the EU Trade Secrets Directive and its impact on the life sciences industry.
par Dr Paul England
par plusieurs auteurs
par plusieurs auteurs